Self-assembled PROTACs enable glycoproteins degradation in the living cells

Haoyu Chen1, Liu Zang1, Pavel Kielkowski1

  • 1Department of Chemistry, LMU Munich Würmtalstr. 201 81375 Munich Germany pavel.kielkowski@cup.lmu.de.

Chemical Science
|April 10, 2025
PubMed

Insights

This study introduces GlyTAC, a novel proteolysis targeting chimera (PROTAC) strategy that degrades cancer cell glycoproteins. GlyTAC utilizes modified sugars to selectively eliminate target proteins, offering a potential new cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Aberrant protein glycosylation is a hallmark of cancer.
  • Targeting glycoproteins is a promising strategy for cancer therapy.
  • Proteolysis targeting chimeras (PROTACs) offer a method for targeted protein degradation.

Purpose of the Study:

  • To develop a novel PROTAC strategy targeting O-GalNAcylated and O-GlcNAcylated proteins.
  • To investigate the potential of this strategy for cancer therapy.
  • To leverage metabolic incorporation of modified sugars for targeted protein degradation.

Main Methods:

  • Metabolic incorporation of azido-modified N-acetylglucosamine (GlcNAc) or N-acetylgalactosamine (GalNAc) analogues into glycoproteins.
  • Strain-promoted azide-alkyne cycloaddition (SPAAC) to attach a thalidomide moiety, recruiting E3 ligase cereblon (CRBN).
  • Induction of ubiquitination and proteasomal degradation of targeted glycoproteins in human cancer cell lines.

Main Results:

  • Demonstrated selective degradation of O-GalNAcylated and O-GlcNAcylated proteins in cancer cells.
  • Observed significant toxicity in human cancer cell lines due to pathway perturbation.
  • Verified the mechanistic pathway through control experiments at each stage.

Conclusions:

  • GlyTAC is an efficient two-component PROTAC system for targeted glycoprotein degradation.
  • The strategy shows potential for cancer therapy due to cancer-specific glycosylation patterns.
  • Further investigation may lead to novel therapeutic approaches for cancer treatment.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.4K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.6K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
650
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.5K